about
Olodaterol attenuates citric acid-induced cough in naïve and ovalbumin-sensitized and challenged guinea pigsComparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trialsThe beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.Emerging Therapeutic Options for the Management of COPD.Indacaterol-induced severe constipation and abdominal pain: is there a role for colonic β3-adrenoceptors?Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Indacaterol: a novel long-acting β(2) -agonist.
@en
type
label
Indacaterol: a novel long-acting β(2) -agonist.
@en
prefLabel
Indacaterol: a novel long-acting β(2) -agonist.
@en
P2093
P2860
P1433
P1476
Indacaterol: a novel long-acting β(2) -agonist.
@en
P2093
Andrea S Franks
James C McMillen
Robert S Helmer
Sarah A Treadway
Shaunta' M Ray
P2860
P304
P356
10.1002/J.1875-9114.2012.01025.X
P407
P577
2012-04-12T00:00:00Z